Does Immune Stimulation or Antioxidant Therapy Reduce MNU-induced Placental Damage Via Activation of Jak-STAT and NFκB Signaling Pathways?

Placenta

Volumn 28, Issue 5-6, 2007, Pages 566-570

  Prater, M R ^a,b   Laudermilch, C L ^b   Holladay, S D ^b  

^a EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

Cytokine; Jak STAT pathway; Methylnitrosourea; NF B pathway; Oxidative stress

Indexed keywords

ANTIOXIDANT; BUTYLCRESOL; CYTOKINE; FREUND ADJUVANT; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; JANUS KINASE; LEPTIN; METHYLNITROSOUREA; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT PROTEIN; THROMBOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MECHANISM; FEMALE; FETUS MALFORMATION; GENE ACTIVATION; GESTATIONAL AGE; IMMUNITY; IMMUNOSTIMULATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLACENTA; PLACENTA DISORDER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIOXIDANTS; CYTOKINES; FEMALE; JANUS KINASES; METHYLNITROSOUREA; MICE; NF-KAPPA B; PLACENTA; PREGNANCY; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34247369378     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2006.05.002     Document Type: Article

References (55)

1. Alexandrov V.A. Some results and prospects of transplacental carcinogenesis studies. Neoplasma 23 (1976) 285-299
2. Prater M.R., Zimmerman K.L., Ward D.L., and Holladay S.D. Reduced birth defects caused by maternal immune stimulation in methylnitrosourea-exposed mice: association with placental improvement. Birth Defects Res Part A Clin Mol Teratol 70 (2004) 862-869
3. Drablos F., Feyzi E., Aas P.A., Vaagbo C.B., Kavli B., Bratlie M.S., et al. Alkylation damage in DNA and RNA-repair mechanisms and medical significance. DNA Repair (Amst) 3 (2004) 1389-1407
4. Prater M.R., Zimmerman K.L., Pinn L.C., Keay J.M., Laudermilch C.L., and Holladay S.D. Role of maternal dietary antioxidant supplementation in murine placental and fetal limb development. Placenta 27 (2006) 502-509
5. Laudermilch C.L., Holladay S.D., Sponenberg D.P., Saunders G.K., Ward D.L., and Prater M.R. Placental improvement and reduced distal limb defects by maternal interferon-gamma injection in methylnitrosourea-exposed mice. Birth Defects Res Part A Clin Mol Teratol 73 (2005) 597-604
6. Holladay S.D., Sharova L.V., Punareewattana K., Hrubec T.C., Gogal Jr. R.M., Prater M.R., et al. Maternal immune stimulation in mice decreases fetal malformations caused by teratogens. Int Immunopharmacol 2 (2002) 325-332
7. Cramer M., Nagy I., Murphy B.J., Gassmann M., Hottiger M.O., Georgiev O., et al. NF-kappaB contributes to transcription of placenta growth factor and interacts with metal responsive transcription factor-1 in hypoxic human cells. Biol Chem 386 (2005) 865-872
8. Bjorbaek C., and Kahn B.B. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59 (2004) 305-331
9. Poehlmann T.G., Busch S., Mussil B., Winzer H., Weinert J., Mebes I., et al. The possible role of the Jak/STAT pathway in lymphocytes at the fetomaternal interface. Chem Immunol Allergy 89 (2005) 26-35
10. Hrubec T.C., Prater M.R., Toops K.A., and Holladay S.D. Reduction in diabetes-induced craniofacial defects by maternal immune stimulation. Birth Defects Res Part B Dev Reprod Toxicol 77 (2006) 1-9
11. Sharova L., Sura P., Smith B.J., Gogal Jr. R.M., Sharov A.A., Ward D.L., et al. Nonspecific stimulation of the maternal immune system. II. Effects on gene expression in the fetus. Teratology 62 (2000) 420-428
12. Smith S.B., Cooke C.B., and Yielding K.L. Effects of the antioxidant butylated hydroxytoluene (BHT) on retinal degeneration induced transplacentally by a single low dosage of N-methyl-N-nitrosourea (MNU). Teratog Carcinog Mutagen 8 (1988) 175-189
13. Schindler C., and Darnell Jr. J.E. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64 (1995) 621-651
14. Reddy E.P., Korapati A., Chaturvedi P., and Rane S. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene 19 (2000) 2532-2547
15. Fitzgerald J.S., Busch S., Wengenmayer T., Foerster K., de la Motte T., Poehlmann T.G., et al. Signal transduction in trophoblast invasion. Chem Immunol Allergy 88 (2005) 181-199
16. Bright J.J., and Sriram S. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J Immunol 161 (1998) 1772-1777
17. Ward A.C., Touw I., and Yoshimura A. The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood 95 (2000) 19-29
18. Decker T., Stockinger S., Karaghiosoff M., Muller M., and Kovarik P. IFNs and STATs in innate immunity to microorganisms. J Clin Invest 109 (2002) 1271-1277
19. Matthiesen L., Berg G., Ernerudh J., Ekerfelt C., Jonsson Y., and Sharma S. Immunology of preeclampsia. Chem Immunol Allergy 89 (2005) 49-61
20. Denison F.C., Kelly R.W., Calder A.A., and Riley S.C. Cytokine secretion by human fetal membranes, decidua and placenta at term. Hum Reprod 13 (1998) 3560-3565
21. Hennessy A., Pilmore H.L., Simmons L.A., and Painter D.M. A deficiency of placental IL-10 in preeclampsia. J Immunol 163 (1999) 3491-3495
22. Wilczynski J.R., Tchorzewski H., Banasik M., Glowacka E., Wieczorek A., Lewkowicz P., et al. Lymphocyte subset distribution and cytokine secretion in third trimester decidua in normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol 109 (2003) 8-15
23. Jonsson Y., Matthiesen L., Berg G., Ernerudh J., Nieminen K., and Ekerfelt C. Indications of an altered immune balance in preeclampsia: a decrease in in vitro secretion of IL-5 and IL-10 from blood mononuclear cells and in blood basophil counts compared with normal pregnancy. J Reprod Immunol 66 (2005) 69-84
24. Makris A., Xu B,Yu B., Thornton C., and Hennessy A. Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta 26 (2005) 828-834
25. Hassink S.G., de Lancey E., Sheslow D.V., Smith-Kirwin S.M., O'Connor D.M., Considine R.V., et al. Placental leptin: an important new growth factor in intrauterine and neonatal development?. Pediatrics 100 (1997) [E1]
26. Bajoria R., Sooranna S.R., Ward B.S., and Chatterjee R. Prospective function of placental leptin at maternal-fetal interface. Placenta 23 (2002) 103-115
27. Ashworth C.J., Hoggard N., Thomas L., Mercer J.G., Wallace J.M., and Lea R.G. Placental leptin. Rev Reprod 5 (2000) 18-24
28. Sagawa N., Yura S., Itoh H., Mise H., Kakui K., Korita D., et al. Role of leptin in pregnancy - a review. Placenta 23 Suppl. A (2002) S80-S86
29. Nilsson C., Swolin-Eide D., Ohlsson C., Eriksson E., Ho H.P., Bjorntorp P., et al. Reductions in adipose tissue and skeletal growth in rat adult offspring after prenatal leptin exposure. J Endocrinol 176 (2003) 13-21
30. Javaid M.K., Godfrey K.M., Taylor P., Robinson S.M., Crozier S.R., Dennison E.M., et al. Umbilical cord leptin predicts neonatal bone mass. Calcif Tissue Int 76 (2005) 341-347
31. Lappas M., Permezel M., and Rice G.E. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 1/2. Endocrinology 146 (2005) 3334-3342
32. Meissner U., Spranger R., Lehner M., Allabauer I., Rascher W., and Dotsch J. Hypoxia-induced leptin production in human trophoblasts does not protect from apoptosis. Eur J Endocrinol 153 (2005) 455-461
33. Meller M., Qiu C., Vadachkoria S., Abetew D.F., Luthy D.A., and Williams M.A. Changes in placental adipocytokine gene expression associated with gestational diabetes mellitus A. Physiol Res (2005) [epub ahead of print]
34. Rahmouni K., and Haynes W.G. Endothelial effects of leptin: implications in health and diseases. Curr Diab Rep 5 (2005) 260-266
35. Singh H.J., Abu Bakar A., Che Romli A., and Nila A. Raised leptin concentrations in feto-placental tissues from women with preeclampsia. Hypertens Pregnancy 24 (2005) 191-199
36. Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem J 393 (2006) 7-20
37. Hayashi M., Hamada Y., and Ohkura T. Elevation of granulocyte-macrophage colony-stimulating factor in the placenta and blood in preeclampsia. Am J Obstet Gynecol 190 (2004) 456-461
38. Dong M., He J., Wang Z., Xie X., and Wang H. Placental imbalance of Th1- and Th2-type cytokines in preeclampsia. Acta Obstet Gynecol Scand 84 (2005) 788-793
39. Frolich M., Datta S., and Corn S.B. Thrombopoietin in normal pregnancy and preeclampsia. Am J Obstet Gynecol 179 (1998) 100-104
40. Karalis I., Nadar S.K., Al Yemeni E., Blann A.D., and Lip G.Y. Platelet activation in pregnancy-induced hypertension. Thromb Res 116 (2005) 377-383
41. Walch L., Massade L., Dufilho M., Brunet A., and Rendu F. Pro-atherogenic effect of interleukin-4 in endothelial cells: modulation of oxidative stress, nitric oxide and monocyte chemoattractant protein-1 expression. Atherosclerosis (2005) [epub ahead of print]
42. Tamasi L., Bohacs A., Pallinger E., Falus A., Rigo Jr. J., Muller V., et al. Increased interferon-gamma- and interleukin-4-synthesizing subsets of circulating T lymphocytes in pregnant asthmatics. Clin Exp Allergy 35 (2005) 1197-1203
43. Guo A., Zhang M., Tang H., and Cao X. Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines. Blood 106 (2005) 2033-2041
44. Poppema S. Immunobiology and pathophysiology of hodgkin lymphomas. Hematology (Am Soc Hematol Educ Program) (2005) 231-238
45. Aban M., Cinel L., Arslan M., Dilek U., Kaplanoglu M., Arpaci R., et al. Expression of nuclear factor-kappa B and placental apoptosis in pregnancies complicated with intrauterine growth restriction and preeclampsia: an immunohistochemical study. Tohoku J Exp Med 204 (2004) 195-202
46. Altinoz M.A., and Korkmaz R. NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer. Neoplasma 51 (2004) 239-247
47. Zhang W.J., and Frei B. Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells. FASEB J 15 (2001) 2423-2432
48. Katabuchi H., Yih S., Ohba T., Matsui K., Takahashi K., Takeya M., et al. Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells. Med Electron Microsc 36 (2003) 253-262
49. He Y., Smith S.K., Day K.A., Clark D.E., Licence D.R., and Charnock-Jones D.S. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol 13 (1999) 537-545
50. Knackstedt M.K., Zenclussen A.C., Hertwig K., Hagen E., Dudenhausen J.W., Clark D.A., et al. Th1 cytokines and the prothrombinase fgl2 in stress-triggered and inflammatory abortion. Am J Reprod Immunol 49 (2003) 210-220
51. McKeeman G.C., Ardill J.E., Caldwell C.M., Hunter A.J., and McClure N. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol 191 (2004) 1240-1246
52. Glabowski W., Kurzawa R., Wiszniewska B., Baczkowski T., Marchlewicz M., and Brelik P. Growth factors effects on preimplantation development of mouse embryos exposed to tumor necrosis factor alpha. Reprod Biol 5 (2005) 83-99
53. Takacs P., Kauma S.W., Sholley M.M., Walsh S.W., Dinsmoor M.J., and Green K. Increased circulating lipid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells. FASEB J 15 (2001) 279-281
54. Peng Y., Kwok K.H., Yang P.H., Ng S.S., Liu J., Wong O.G., et al. Ascorbic acid inhibits ROS production, NF-kappa B activation and prevents ethanol-induced growth retardation and microencephaly. Neuropharmacology 48 (2005) 426-434
55. Mackova M., Kilani R.T., Davidge S.T., and Guilbert L.J. The effect of oxygen tension on intracellular survival signaling in primary villous trophoblasts. Placenta 24 (2003) 627-637